These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15217777

  • 1. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure.
    Witham MD, Gillespie ND, Struthers AD.
    Age Ageing; 2004 Sep; 33(5):467-72. PubMed ID: 15217777
    [Abstract] [Full Text] [Related]

  • 2. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW, Jansen RW.
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [Abstract] [Full Text] [Related]

  • 3. Beta-blocker therapy in heart failure in the elderly.
    Fu M.
    Int J Cardiol; 2008 Apr 10; 125(2):149-53. PubMed ID: 18023898
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure.
    Parameswaran AC, Tang WH, Francis GS, Gupta R, Young JB.
    Am Heart J; 2005 May 10; 149(5):921-6. PubMed ID: 15894978
    [Abstract] [Full Text] [Related]

  • 6. Beta blocker therapy for chronic heart failure.
    Ramahi TM.
    Am Fam Physician; 2000 Nov 15; 62(10):2267-74. PubMed ID: 11126853
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Critical analysis of beta blockers in heart failure: certainty and incompleteness].
    Rapezzi C, Branzi A.
    Ital Heart J Suppl; 2000 Aug 15; 1(8):1003-10. PubMed ID: 10993006
    [Abstract] [Full Text] [Related]

  • 9. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV, Ohman EM, Gibler WB, Peterson ED.
    Am J Med; 2007 Aug 15; 120(8):685-92. PubMed ID: 17679127
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment and risk in heart failure: gaps in evidence or quality?
    Peterson PN, Rumsfeld JS, Liang L, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA, American Heart Association Get With The Guidelines-Heart Failure Program.
    Circ Cardiovasc Qual Outcomes; 2010 May 15; 3(3):309-15. PubMed ID: 20388872
    [Abstract] [Full Text] [Related]

  • 12. Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials.
    Estep JD, Mehta SK, Uddin F, King L, Toto KH, Nelson LL, Dries DL, Yancy CW, Drazner MH.
    Am Heart J; 2004 Dec 15; 148(6):958-63. PubMed ID: 15632878
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators.
    Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343
    [Abstract] [Full Text] [Related]

  • 15. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
    Haas SJ, Vos T, Gilbert RE, Krum H.
    Am Heart J; 2003 Nov 29; 146(5):848-53. PubMed ID: 14597934
    [Abstract] [Full Text] [Related]

  • 16. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
    Chan JD, Rea TD, Smith NL, Siscovick D, Heckbert SR, Lumley T, Chaves P, Furberg CD, Kuller L, Psaty BM.
    Am Heart J; 2005 Sep 29; 150(3):464-70. PubMed ID: 16169325
    [Abstract] [Full Text] [Related]

  • 17. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J, HELUMA study group.
    Eur Heart J; 2005 Dec 29; 26(24):2689-97. PubMed ID: 16183697
    [Abstract] [Full Text] [Related]

  • 18. [Heart failure with conserved systolic function. Therapeutic potential with beta blocking agents].
    Faggiano P, Rusconi C.
    Ital Heart J Suppl; 2000 Aug 29; 1(8):1019-26. PubMed ID: 10993008
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Limited role for ivabradine in the treatment of chronic heart failure.
    Cullington D, Goode KM, Cleland JG, Clark AL.
    Heart; 2011 Dec 29; 97(23):1961-6. PubMed ID: 21917660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.